On August 24, 2021 Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, reported the company will review the interim results and business highlights on Monday, August 30,2021 (Press release, Suzhou Kintor Pharmaceuticals, AUG 24, 2021, https://www.prnewswire.com/news-releases/kintor-pharma-to-report-2021-interim-financial-results-and-host-conference-call-on-august-30-2021-301361359.html [SID1234586863]). You can access the presentation through live webcast or dial-in.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Mandarin Webcast and Teleconference
09:30 a.m. – 10:30 a.m. (Beijing Time)
English Teleconference
09:00 a.m. – 10:00 a.m. (EDT)/ 09:00 p.m.- 10:00 p.m. (Beijing Time)
On the call, Kintor Pharma’s Founder, Chairman & CEO and CFO will provide an update on the company’s business and upcoming milestones. The conference call can be accessed by pre-registration. Once the registration has been approved, an email will be sent with dial-in number and password.
Registration Link: View Source
Please kindly finish registration at least 24 hours before the call.